{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cagrisema", "query": { "intervention": "Cagrisema" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 22, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cagrisema&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T02:43:20.377Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07564414", "title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity", "Type 2 Diabetes" ], "interventions": [ { "name": "Cagrisema", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2500, "start_date": "2026-05-21", "completion_date": "2028-04-19", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-02T02:43:20.377Z", "location_count": 99, "location_summary": "Birmingham, Alabama • Pelham, Alabama • Gilbert, Arizona + 81 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Pelham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "nct_id": "NCT06323161", "title": "A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Cagrilintide", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 274, "start_date": "2024-03-26", "completion_date": "2025-10-23", "has_results": false, "last_update_posted_date": "2025-11-28", "last_synced_at": "2026-09-02T02:43:20.377Z", "location_count": 14, "location_summary": "Northridge, California • Miami, Florida • Meridian, Idaho + 10 more", "locations": [ { "city": "Northridge", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Meridian", "state": "Idaho" }, { "city": "West Des Moines", "state": "Iowa" }, { "city": "Newton", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06323161" }, { "nct_id": "NCT07357766", "title": "A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Overweight", "Obesity" ], "interventions": [ { "name": "Cagrisema", "type": "DRUG" }, { "name": "Placebo CagriSema", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2026-06-22", "completion_date": "2028-01-17", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-09-02T02:43:20.377Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Pelham, Alabama • Hawthorne, California + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Pelham", "state": "Alabama" }, { "city": "Hawthorne", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Spring Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07357766" }, { "nct_id": "NCT05394519", "title": "A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Overweight", "Obesity", "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Cagrilintide", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Placebo cagrilintide", "type": "DRUG" }, { "name": "Placebo semaglutide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1200, "start_date": "2023-02-01", "completion_date": "2025-02-03", "has_results": false, "last_update_posted_date": "2026-01-28", "last_synced_at": "2026-09-02T02:43:20.377Z", "location_count": 49, "location_summary": "Concord, California • Escondido, California • Fullerton, California + 39 more", "locations": [ { "city": "Concord", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05394519" }, { "nct_id": "NCT06409130", "title": "Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcohol-related Liver Disease" ], "interventions": [ { "name": "NNC0194-0499", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "NNC0194-0499 placebo", "type": "DRUG" }, { "name": "Semaglutide placebo (Group A)", "type": "DRUG" }, { "name": "Cagrilintide + semaglutide", "type": "DRUG" }, { "name": "Cagrilintide", "type": "DRUG" }, { "name": "Cagrilintide placebo", "type": "DRUG" }, { "name": "Semaglutide placebo (Group B)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 270, "start_date": "2024-05-20", "completion_date": "2026-01-12", "has_results": false, "last_update_posted_date": "2026-03-12", "last_synced_at": "2026-09-02T02:43:20.377Z", "location_count": 29, "location_summary": "Chandler, Arizona • Tucson, Arizona • Lancaster, California + 23 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Lancaster", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06409130" }, { "nct_id": "NCT06388187", "title": "A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Cagrilintide", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2024-06-24", "completion_date": "2026-04-22", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-09-02T02:43:20.377Z", "location_count": 7, "location_summary": "Costa Mesa, California • Plantation, Florida • Indianapolis, Indiana + 4 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Plantation", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Wilmington", "state": "North Carolina" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06388187" }, { "nct_id": "NCT06716307", "title": "A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "CagriSema (cagrilintide B and semaglutide I)", "type": "DRUG" }, { "name": "CagriSema A", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 18, "start_date": "2024-12-02", "completion_date": "2025-03-28", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-02T02:43:20.377Z", "location_count": 1, "location_summary": "Lincoln, Nebraska", "locations": [ { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06716307" }, { "nct_id": "NCT06323174", "title": "A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Cagrilintide", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 189, "start_date": "2024-03-19", "completion_date": "2025-12-22", "has_results": false, "last_update_posted_date": "2026-04-02", "last_synced_at": "2026-09-02T02:43:20.377Z", "location_count": 21, "location_summary": "Huntington Park, California • Northridge, California • Santa Ana, California + 18 more", "locations": [ { "city": "Huntington Park", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06323174" }, { "nct_id": "NCT07357740", "title": "A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "CagriSema", "type": "DRUG" }, { "name": "Placebo CagriSema", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 0, "start_date": "2026-08-27", "completion_date": "2027-10-13", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-09-02T02:43:20.377Z", "location_count": 21, "location_summary": "Little Rock, Arkansas • San Diego, California • Spring Valley, California + 16 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "Spring Valley", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Longwood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07357740" }, { "nct_id": "NCT07011667", "title": "A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "CagriSema (Cagrilintide B and Semaglutide I)", "type": "DRUG" }, { "name": "Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 609, "start_date": "2025-06-03", "completion_date": "2028-10-17", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-02T02:43:20.377Z", "location_count": 46, "location_summary": "Costa Mesa, California • San Diego, California • Walnut Creek, California + 41 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Fleming Island", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07011667" } ] }